Return to content in this issue

 

Shortened Up-Dosing With 7 Injections of Subcutaneous Allergy Immunotherapy (Alutard SQ) Is Safe and Well Tolerated

Horn A1, Fernández-Rivas M2, Wolf H3, Ghaussy N3, Møller Kruse T4, Koutromanou K4, Wüstenberg E3,5

1ENT Practice am Neckar, Drs Horn & Choudhry, Heidelberg, Germany
2Allergy Dept, Hospital Clínico San Carlos, IdISSC, ARADyAL, Madrid, Spain
3Medical Department ALK-Abelló Arzneimittel GmbH, Hamburg, Germany
4ALK Global Pharmacovigilance and Clinical Development, Hørsholm, Denmark
5ENT Clinic Medical Faculty Carl-Gustav-Carus, Technical University, Dresden, Germany

J Investig Allergol Clin Immunol 2021; Vol 31(1) : 80-83
doi: 10.18176/jiaci.0561

Key words: Adverse events, Safety, Short up-dosing, Subcutaneous allergy immunotherapy, Tolerability